BrightMeds Hidden Fees: The Complete Cost Breakdown for GLP-1 Weight

Last updated: September 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds charges $129 per month for compounded semaglutide and $149 per month for compounded tirzepatide on month-to-month plans, with medication, provider visits, follow-up, dose adjustments, support, and shipping included—no separate membership, lab, prescribing, or shipping fees (captured September 4, 2026). The advertised price is the total recurring cost at any dose. A 3-month prepaid promotional plan offers a lower effective monthly rate ($99 for semaglutide, $119 for tirzepatide) but requires upfront payment every three months. Over 12 months, BrightMeds' promotional plan costs $1,188 for semaglutide or $1,428 for tirzepatide, compared to PlexusDx's 6-month semaglutide plan at $1,788 annually or tirzepatide at $2,988 annually. BrightMeds wins on price; PlexusDx offers broader dose flexibility across oral, injection, and microdose protocols. The promotional pricing is described as a "summer special" and may be state-limited or time-limited; confirm availability and terms at checkout.

At-a-glance comparison

Captured September 4, 2026 (BrightMeds), July 17–23 and September 9, 2026 (PlexusDx).

What BrightMeds includes: no hidden fees confirmed

BrightMeds advertises "all-inclusive" month-to-month pricing: the $129 semaglutide or $149 tirzepatide monthly charge covers medication, provider evaluation, follow-up visits, dose adjustments, ongoing support, and shipping, with no separate membership, lab, or prescribing fees (brightmeds.com, captured September 4, 2026). The price remains constant regardless of dose—patients titrating from starter to maintenance pay the same monthly rate. This structure eliminates common hidden-fee pitfalls seen in competitor programs that unbundle visits, labs, or tiered dosing.

The program offers two commitment paths: a month-to-month plan at the standard rates above, and a 3-month prepaid promotional plan that reduces the effective monthly cost to $99 for semaglutide (requiring $297 upfront) or $119 for tirzepatide (requiring $357 upfront). The promotional pricing is labeled a "summer special" on BrightMeds' landing page and may be subject to state or time limitations; eligibility should be confirmed during checkout. Both plans include the same services; the difference is the prepayment commitment and the per-month equivalent rate.

BrightMeds promotional vs. standard pricing

BrightMeds' standard month-to-month plan charges $129 per month for semaglutide with no upfront commitment, totaling $1,548 over 12 months (our calculation: $129 × 12). The 3-month prepaid promotional plan requires $297 every three months, yielding an effective rate of $99 per month and a 12-month cost of $1,188 (our calculation: $297 × 4 cycles). The promotional plan saves $360 annually on semaglutide but demands four separate $297 payments across the year.

For tirzepatide, the standard month-to-month rate is $149 per month ($1,788 annually, our calculation), while the 3-month prepaid promotional plan costs $357 every three months ($119 per month effective, $1,428 annually, our calculation). The promotional tirzepatide plan saves $360 over 12 months compared to paying month-to-month.

Both promotional rates were captured September 4, 2026, from BrightMeds' summer-special landing page. The standard monthly rates remain the baseline for patients who prefer monthly billing flexibility or cannot prepay quarterly.

BrightMeds vs. PlexusDx: like-for-like 12-month costs

Comparing month-to-month plans (no prepay required): BrightMeds semaglutide costs $1,548 annually versus PlexusDx semaglutide injection at $2,268 annually (our calculation: $189 × 12)—a $720 annual advantage for BrightMeds. BrightMeds tirzepatide costs $1,788 annually versus PlexusDx tirzepatide injection at $3,468 annually (our calculation: $289 × 12)—a $1,680 annual advantage for BrightMeds.

Comparing 3-month prepaid plans: BrightMeds' promotional 3-month semaglutide plan costs $1,188 annually (our calculation: $297 upfront × 4) versus PlexusDx's 3-month semaglutide plan at $2,028 annually (our calculation: $169 per month × 12, billed as three $507 charges). BrightMeds saves $840 over the year. For tirzepatide, BrightMeds' 3-month promotional plan costs $1,428 annually (our calculation: $357 × 4) versus PlexusDx's 3-month tirzepatide plan at $3,228 annually (our calculation: $269 × 12, billed as three $807 charges)—a $1,800 annual difference favoring BrightMeds.

PlexusDx also offers 6-month prepaid plans: semaglutide at $1,788 annually ($149 per month, billed as two $894 charges) and tirzepatide at $2,988 annually ($249 per month, billed as two $1,494 charges). Even at PlexusDx's lowest per-month rate, BrightMeds' promotional pricing undercuts both compounds by $600 (semaglutide) and $1,560 (tirzepatide) over 12 months.

All 12-month totals are our calculations. BrightMeds promotional rates captured September 4, 2026; PlexusDx prices recorded July 17–23, 2026.

Decision factors beyond price

Service quality and reviews

BrightMeds displays a 4.8-star Trustpilot rating with more than 900 reviews (captured September 4, 2026, from the provider's page). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Both programs report strong satisfaction; BrightMeds' higher volume and rating suggest established operational consistency. No specific negative themes were documented for BrightMeds during research; routine due diligence—reading recent reviews and confirming responsiveness during intake—remains prudent for any telehealth provider.

Medication routes and protocol breadth

BrightMeds offers compounded semaglutide and tirzepatide injections. PlexusDx provides the same injections plus oral semaglutide capsules ($289 month-to-month), oral tirzepatide capsules ($349 month-to-month), and a microdose semaglutide injection protocol ($129 month-to-month) designed for patients approaching goal weight or seeking maintenance dosing. If injection aversion, needle anxiety, or a lower-dose maintenance option is relevant, PlexusDx's protocol variety may offset the price difference. If standard injection therapy at the lowest possible cost is the priority, BrightMeds' promotional pricing is decisively more affordable.

Geographic and promotional limitations

BrightMeds' promotional 3-month rates are described as a "summer special" and noted as state-limited (brightmeds.com, captured September 4, 2026). The standard month-to-month pricing appears broadly available, but eligibility for the promotional tier should be confirmed during intake. Promotional windows may close or terms may change; locking in the lower rate via the 3-month prepaid plan secures the discount for that cycle but requires renewal at the then-current rate. PlexusDx pricing is nationally published with no seasonal promotion dependency.

Choose BrightMeds if…

• You want the lowest documented all-in GLP-1 price and can commit to 3-month prepaid cycles ($99/month semaglutide, $119/month tirzepatide effective rate).
• You prefer month-to-month flexibility and BrightMeds' $129 semaglutide or $149 tirzepatide standard rate still undercuts alternatives meaningfully.
• Compounded injection therapy meets your needs and you do not require oral or microdose options.
• You qualify under BrightMeds' state-availability rules and the promotional offer remains active.
• You value the program's 4.8-star Trustpilot rating and 900+ review volume as evidence of service consistency.

Where PlexusDx fits

PlexusDx costs more than BrightMeds on a per-month injection basis but offers broader clinical flexibility: oral semaglutide and tirzepatide for patients who cannot or prefer not to inject, and a $129 microdose semaglutide protocol for maintenance-phase patients. The month-to-month semaglutide injection ($189) and tirzepatide injection ($289) remain competitive against many telehealth providers, though not against BrightMeds' promotional or standard rates. PlexusDx publishes one transparent national price with no seasonal promotion dependency, no state exclusions documented, and the same all-inclusive structure (medication, visits, adjustments, shipping, no membership or lab fees). If route variety, lower-dose protocols, or predictable non-promotional pricing align better with your clinical or financial planning, PlexusDx is the practical alternative. If price is the dominant factor and standard injection therapy suffices, BrightMeds' documented rates deliver measurably lower annual costs.

Methodology and freshness

BrightMeds pricing, fee structure, and inclusions were captured September 4, 2026, from the provider's landing page (brightmeds.com) and Trustpilot profile. The promotional 3-month rates ($99 semaglutide, $119 tirzepatide monthly equivalents) are labeled as summer-special offers and may be time-limited or state-limited; standard month-to-month rates ($129 semaglutide, $149 tirzepatide) were also documented on the same date. PlexusDx pricing was recorded July 17–23, 2026; PlexusDx Trustpilot data captured September 9, 2026. All 12-month cost projections—$1,188 BrightMeds promotional semaglutide, $1,548 BrightMeds standard semaglutide, $1,428 BrightMeds promotional tirzepatide, $1,788 BrightMeds standard tirzepatide, $2,268 PlexusDx month-to-month semaglutide, $2,028 PlexusDx 3-month semaglutide, $1,788 PlexusDx 6-month semaglutide, $3,468 PlexusDx month-to-month tirzepatide, $3,228 PlexusDx 3-month tirzepatide, and $2,988 PlexusDx 6-month tirzepatide—are our calculations (monthly rate × 12 or quarterly charge × 4). Prepaid per-month equivalents ($99, $119 BrightMeds; $169, $269, $149, $249 PlexusDx) are derived from the documented prepaid totals and labeled as such. This article reflects evidence available as of September 21, 2026; confirm current pricing, promotional eligibility, and terms at checkout.

Frequently Asked Questions

Does BrightMeds charge separate visit or lab fees?

No. BrightMeds' advertised monthly price includes the provider evaluation, follow-up visits, dose adjustments, and ongoing support with no separate prescribing, lab, or membership fees (captured September 4, 2026). Shipping is also included. The $129 semaglutide or $149 tirzepatide rate is the total recurring cost.

How much does BrightMeds cost over 12 months?

On the standard month-to-month plan, semaglutide costs $1,548 annually and tirzepatide $1,788 (our calculations). The 3-month prepaid promotional plan costs $1,188 for semaglutide (effective $99/month) and $1,428 for tirzepatide (effective $119/month), requiring four quarterly prepayments of $297 or $357 respectively.

Is BrightMeds' promotional pricing available in all states?

BrightMeds describes the 3-month promotional rate as a "summer special" and notes state limitations (captured September 4, 2026). Eligibility and current availability should be confirmed during intake. The standard month-to-month pricing may have broader geographic availability; check at checkout.

Are BrightMeds medications FDA-approved?

No. BrightMeds dispenses compounded semaglutide and tirzepatide, which are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

How does PlexusDx pricing compare to BrightMeds?

PlexusDx semaglutide injection costs $189 month-to-month, $169 on a 3-month plan, or $149 on a 6-month plan versus BrightMeds' $129 standard or $99 promotional (3-month prepaid). PlexusDx tirzepatide costs $289, $269, or $249 respectively versus BrightMeds' $149 standard or $119 promotional. BrightMeds is less expensive; PlexusDx offers additional oral and microdose protocols.

Sources

• BrightMeds official website (brightmeds.com), pricing and inclusions; accessed September 4, 2026
• BrightMeds Trustpilot profile (trustpilot.com), rating and review volume; accessed September 4, 2026
• PlexusDx product pages (plexusdx.com), semaglutide and tirzepatide injection pricing; accessed July 17–23, 2026
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), rating and distribution; accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.